Tag Palbociclib

Palbociclib, sold under the brand name Ibrance . It is a medication specifically designed to target and treat hormone receptor-positive (HR+) and HER2-negative (HER2-) advanced or metastatic breast cancer.

Breast Cancer, Ovarian Cancer

PARP Inhibitors in Ovarian and Breast Cancer Treatment

A PARP inhibitor is a cancer drug that blocks the activity of poly(ADP-ribose) polymerase (PARP), a protein crucial for DNA repair, leading to cell death in various cancers, including ovarian, breast, prostate, pancreatic, and fallopian tube cancers.